NVAX

NOVAVAX INC

Healthcare | Small Cap

-$0.66

EPS Forecast

$96.59

Revenue Forecast

Announcing earnings for the quarter ending 2024-12-31 soon
REPLReplimune Group IncBLUEBluebird Bio IncCRSPCrispr Therapeutics AgDNLIDenali Therapeutics IncHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncNBIXNeurocrine Biosciences IncRGENRepligen CorpTECHBio-techne CorpMRNAModerna Inc